GE launches new programmable bioreactor for seed chain and process dev
GE Healthcare has launched new single-use, bioreactor for seed train and process development operations and mAb production.
GE Healthcare has launched new single-use, bioreactor for seed train and process development operations and mAb production.
UK-based fermentor maker TAP Biosystems has approved the €33m ($45m) takeover bid by Sartorius.
Kadcyla has become the second antibody-drug conjugate (ADC) to be available in Europe, triggering a $5m milestone payment by Roche to technology partner Immunogen.
Parexel has seen small and mid-sized biopharma demand for development services decline in recent months according to an anaylst who attended the CROs presentation at the Jefferies Global Healthcare conference this week.